Author

Eileen Wolff

Institution: Ichnos Sciences (United States)

Observed institution: Ichnos Sciences (United States)

OpenAlex ID: A5079375725

Initial Results of Dose Escalation of ISB 1342, a Novel CD3xCD38 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

2022 · Sanjay R Mohan, Cristiana Costa Chase, et al. · Blood · 14

Dose Escalation of ISB 1342, a Novel CD38xCD3 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

2023 · Prashant Kapoor, Don A. Stevens, et al. · Blood · 12

A Phase 1, First-in-Human, Dose Escalation and Dose-Expansion Study of a BCMAxCD38xCD3 Targeting Trispecific Antibody ISB 2001 in Subjects with Relapsed/Refractory Multiple Myeloma

2023 · Hanlon Sia, Vinu Menon, et al. · Blood · 6

Works count: 3

Citation count: 32

H-index: 3

I10-index: 2